CAM
UTHR icon

Cresset Asset Management’s United Therapeutics UTHR Stock Holding History

Cresset Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
4,320
-12
-0.3% -$6.76K 0.01% 622
2026
Q1 		$2.57M Buy
4,332
+70
+2% +$34.9K 0.01% 500
2025
Q4 		$2.08M Sell
4,262
-289
-6% -$135K 0.01% 559
2025
Q3 		$1.91M Buy
4,551
+54
+1% +$18.2K 0.01% 544
2025
Q2 		$1.29M Sell
4,497
-4,190
-48% -$1.25M 0.01% 623
2025
Q1 		$2.68M Buy
8,687
+108
+1% +$37K 0.01% 458
2024
Q4 		$3.03M Sell
8,579
-811
-9% -$298K 0.01% 447
2024
Q3 		$3.36M Buy
9,390
+458
+5% +$155K 0.01% 581
2024
Q2 		$2.85M Buy
8,932
+908
+11% +$240K 0.01% 581
2024
Q1 		$1.84M Buy
8,024
+1,112
+16% +$251K 0.01% 680
2023
Q4 		$1.52M Buy
6,912
+1,127
+19% +$260K 0.01% 703
2023
Q3 		$1.31M Buy
5,785
+731
+14% +$168K 0.01% 719
2023
Q2 		$1.12M Buy
+5,054
New +$1.12M ﹤0.01% 892
2022
Q1 		– Sell
-2,254
Closed -$488K – 1149
2021
Q4 		$488K Buy
2,254
+256
+13% +$50.3K ﹤0.01% 708
2021
Q3 		$368K Buy
1,998
+20
+1% +$3.94K 0.01% 748
2021
Q2 		$355K Sell
1,978
-1
-0.1% -$190 0.01% 696
2021
Q1 		$331K Buy
+1,979
New +$330K 0.01% 634
2019
Q2 		– Sell
-638
Closed -$75K – 1652
2019
Q1 		$75K Buy
638
+628
+6,280% +$73.2K ﹤0.01% 655
2018
Q4 		$1K Buy
+10
New +$1.16K ﹤0.01% 1613

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cresset Asset Management's UTHR Position: Q2 2026 in Review

Cresset Asset Management reduced its United Therapeutics (UTHR) stake by 0.28% in Q2 2026, selling an estimated $6.76K and leaving 4,320 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #622.

Cresset Asset Management first reported a position in UTHR in Q4 2018 and has held it in 19 quarters since. The position peaked at $3.36M in Q3 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cresset Asset Management held 4,320 shares of United Therapeutics worth $2.34M as of Q2 2026.
  • Cresset Asset Management sold 12 United Therapeutics shares in Q2 2026, an estimated $6.76K.
  • United Therapeutics made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #622 holding.
  • Cresset Asset Management first reported a position in United Therapeutics in Q4 2018 and has held it in 19 quarters since.
  • Cresset Asset Management's United Therapeutics position peaked at $3.36M in Q3 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.